Genomic Profiling of Cancers of Unknown Primary Site--Reply

Affiliations

¹ Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York2Foundation Medicine, Inc, Cambridge, Massachusetts.
² Foundation Medicine, Inc, Cambridge, Massachusetts.

Comment

Jeffrey S Ross et al. JAMA Oncol. 2015 Jul.

. 2015 Jul;1(4):542-3.

doi: 10.1001/jamaoncol.2015.0945.

¹ Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York2Foundation Medicine, Inc, Cambridge, Massachusetts.
² Foundation Medicine, Inc, Cambridge, Massachusetts.

No abstract available

Comment on

Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
Whang YE, Hayes DN. Whang YE, et al. JAMA Oncol. 2015 Jul;1(4):541. doi: 10.1001/jamaoncol.2015.0936. JAMA Oncol. 2015. PMID: 26181266 No abstract available.
Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
Varghese AM, Saltz LB. Varghese AM, et al. JAMA Oncol. 2015 Jul;1(4):541-2. doi: 10.1001/jamaoncol.2015.0939. JAMA Oncol. 2015. PMID: 26181267 No abstract available.
Genomic Profiling of Cancers of Unknown Primary Site: The Next Steps.
Cobain EF, Chinnaiyan AM, Kurzrock R, Baker LH. Cobain EF, et al. JAMA Oncol. 2015 Jul;1(4):542. doi: 10.1001/jamaoncol.2015.0942. JAMA Oncol. 2015. PMID: 26181268 No abstract available.
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.
Ross JS, Wang K, Gay L, Otto GA, White E, Iwanik K, Palmer G, Yelensky R, Lipson DM, Chmielecki J, Erlich RL, Rankin AN, Ali SM, Elvin JA, Morosini D, Miller VA, Stephens PJ. Ross JS, et al. JAMA Oncol. 2015 Apr;1(1):40-49. doi: 10.1001/jamaoncol.2014.216. JAMA Oncol. 2015. PMID: 26182302